New AIDS vaccine has been tested successfully on mice and now we will conduct a new test period, small scale, tightly controlled in patients positive for HIV is not in the final stages of the disease "- Enrique Iglesias researchers said.
Iglesias, head of vaccine development team at the Central biotechnology and genetically modified (CIGB), said at a conference of International Biotechnology Havana 2012, which began on 5/3 in the capital La Havana.
bieutuongAIDS.jpg
The Cuban biotech is ready to test AIDS vaccine on humans
He claims TERAVAC-vaccine made from HIV-1 proteins are combined together to form "response at the cellular level against the HIV virus." But he also said that should not be too forward to the success of the program.
"So far, more than 100 treatment trials on the human body related to HIV virus in Cuba and other countries and all have failed" - Iglesias said.
About 600 scientists from 38 countries participated in the event, including Nobel laureate chemist Peter Agre of America, who also is a physician and molecular biologist.
No comments:
Post a Comment